Advanced Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: June 28, 2024 Report Code: GDME1769EPD-ST

Select Item

Advanced Ablation Catheters Pipeline Market Report Overview

Advanced ablation catheters utilize features and methods beyond those of standard ablation catheters. Advanced ablation catheters tracked are irrigated tip RF ablation catheters, cryoablation catheters, and laser ablation catheters.

The advanced ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Irrigated tip RF Ablation Catheters

·       Cryoablation Catheters

·       Laser Ablation Catheters
Key Territories ·       Europe

·       The United States

·       China

·       Hong Kong

·       Japan
Key Regulatory Paths ·       CE

·       510(k)

·       NMPA

·       PMA

·       MDCO

·       Ninsho
Leading Companies ·       Apama Medical Inc

·       Biosense Webster Inc

·       CathRx Ltd

·       Ethicon US LLC

·       Farapulse Inc
Enquire & Decide

Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Advanced Ablation Catheters Pipeline Market Segmentation by Segments

The key segments in the advanced ablation catheters pipeline market are irrigated tip RF ablation catheters, cryoablation catheters, and laser ablation catheters. As of June 2024, irrigated tip RF ablation catheters accounted for the highest number of pipeline products.

Advanced Ablation Catheters Pipeline Market Analysis by Segments, 2024 (%)

Advanced Ablation Catheters Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Advanced Ablation Catheters Pipeline Market

Download a Free Report Sample

Advanced Ablation Catheters Pipeline Market Segmentation by Territories

A few of the key territories with the advanced ablation catheters pipeline market are Europe, the United States, China, Hong Kong, Japan, and Macau among others. As of June 2024, Europe and the United States had an equal number of advanced ablation catheters pipeline products.

Advanced Ablation Catheters Pipeline Market Analysis by Territories, 2024 (%)

Advanced Ablation Catheters Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Advanced Ablation Catheters Pipeline Market

Download a Free Report Sample

Advanced Ablation Catheters Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the advanced ablation catheters pipeline products market are CE, 510(k), NMPA, PMA, MDCO, and Ninsho. As of June 2024, CE was the most followed pathway for pipeline products in the advanced ablation catheters market.

Advanced Ablation Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Advanced Ablation Catheters Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Advanced Ablation Catheters Pipeline Market

Download a Free Report Sample

Advanced Ablation Catheters Pipeline Market – Competitive Landscape

A few of the key companies associated with the advanced ablation catheters pipeline market are Apama Medical Inc, Biosense Webster Inc, CathRx Ltd, Ethicon US LLC, and Farapulse Inc, among others.

Apama Medical Inc: Apama Medical Inc is a medical device company, headquartered in Campbell, California, the US. The company provides innovative solutions that address unmet clinical needs in the underpenetrated and rapidly growing atrial fibrillation (AF) market.

Biosense Webster Inc: Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures, and markets cardiac arrhythmias products. The company is headquartered in Diamond Bar, California, the US. Biosense Webster provides onsite training, offsite workshops, online training, EP training, and professional and medical education services.

Advanced Ablation Catheters Pipeline Market Analysis by Companies, 2024
Advanced Ablation Catheters Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Advanced Ablation Catheters Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Advanced Ablation Catheters Pipeline Market Segments Outlook (2024)

  • Irrigated tip RF Ablation Catheters
  • Cryoablation Catheters
  • Laser Ablation Catheters

Advanced Ablation Catheters Pipeline Market Territories Outlook (2024)

  • Europe
  • The United States
  • China
  • Hong Kong
  • Japan
  • Macau

Advanced Ablation Catheters Pipeline Market Regulatory Paths Outlook (2024)

  • CE
  • 510(k)
  • NMPA
  • PMA
  • MDCO
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the advanced ablation catheters under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of advanced ablation catheters and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of advanced ablation catheters under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Apama Medical Inc
Biosense Webster Inc
Boston Scientific Corp
CardioFocus Inc
CathRx Ltd
Cibiem, Inc.
CryoTherapeutics SA
Ethicon US LLC
Farapulse Inc
Japan Lifeline Co Ltd
Medlumics SL
MicroPort Scientific Corp
Shanghai HeartCare Medical Technology Co Ltd
St. Jude Medical LLC
Stereotaxis Inc
Vanderbilt University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Advanced Ablation Catheters Overview 8

3 Products under Development 9

3.1 Advanced Ablation Catheters – Pipeline Products by Stage of Development 9

3.2 Advanced Ablation Catheters – Pipeline Products by Segment 10

3.3 Advanced Ablation Catheters – Pipeline Products by Territory 11

3.4 Advanced Ablation Catheters – Pipeline Products by Regulatory Path 12

3.5 Advanced Ablation Catheters – Pipeline Products by Estimated Approval Date 13

3.6 Advanced Ablation Catheters – Ongoing Clinical Trials 14

4 Advanced Ablation Catheters – Pipeline Products under Development by Companies 15

4.1 Advanced Ablation Catheters Companies – Pipeline Products by Stage of Development 15

4.2 Advanced Ablation Catheters – Pipeline Products by Stage of Development 16

5 Advanced Ablation Catheters Companies and Product Overview 17

5.1 Apama Medical Inc Company Overview 17

5.1.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Biosense Webster Inc Company Overview 18

5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Boston Scientific Corp Company Overview 23

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 CardioFocus Inc Company Overview 25

5.4.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 CathRx Ltd Company Overview 28

5.5.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Cibiem, Inc. Company Overview 29

5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 CryoTherapeutics SA Company Overview 30

5.7.1 CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Ethicon US LLC Company Overview 33

5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.9 Farapulse Inc Company Overview 34

5.9.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 Japan Lifeline Co Ltd Company Overview 37

5.10.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.11 Medlumics SL Company Overview 38

5.11.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 38

5.12 MicroPort Scientific Corp Company Overview 39

5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 Shanghai HeartCare Medical Technology Co Ltd Company Overview 40

5.13.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 St. Jude Medical LLC Company Overview 41

5.14.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Stereotaxis Inc Company Overview 42

5.15.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Vanderbilt University Company Overview 45

5.16.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 45

6 Advanced Ablation Catheters- Recent Developments 46

6.1 Jun 13, 2024: Medtronic Confirms Global Layoffs 46

6.2 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team 46

6.3 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 46

6.4 May 16, 2024: Biosense Webster to Present Data from 42 Company-Sponsored or Funded Studies, Including PFA and RF Innovation, at Heart Rhythm Society Annual Meeting 46

6.5 May 14, 2024: CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024 47

6.6 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 48

6.7 Apr 09, 2024: First Look at Data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF Platform for Atrial Fibrillation Presented at EHRA Congress 48

6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 50

6.9 Mar 04, 2024: Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States 50

6.10 Jan 08, 2024: Stereotaxis Announces First Patients Successfully Treated using MAGiC Ablation Catheter 50

6.11 Dec 14, 2023: Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation 51

6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 52

6.13 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 52

6.14 Aug 23, 2023: Boston Scientific Obtains Pre-Market Approval (PMA) for POLARx FIT Cryoablation Balloon Catheter 52

6.15 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 52

7 Appendix 54

7.1 Methodology 54

7.2 About GlobalData 57

7.3 Contact Us 57

7.4 Disclaimer 57

Table

Advanced Ablation Catheters – Pipeline Products by Stage of Development 9

Advanced Ablation Catheters – Pipeline Products by Segment 10

Advanced Ablation Catheters – Pipeline Products by Territory 11

Advanced Ablation Catheters – Pipeline Products by Regulatory Path 12

Advanced Ablation Catheters – Pipeline Products by Estimated Approval Date 13

Advanced Ablation Catheters – Ongoing Clinical Trials 14

Advanced Ablation Catheters Companies – Pipeline Products by Stage of Development 15

Advanced Ablation Catheters – Pipeline Products by Stage of Development 16

Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17

LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Status 17

LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Description 17

Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 18

CARTO SMARTTOUCH 5D Catheter – Product Status 18

CARTO SMARTTOUCH 5D Catheter – Product Description 18

Thermocool Smarttouch SF Dual Energy Catheter – Product Status 19

Thermocool Smarttouch SF Dual Energy Catheter – Product Description 19

Biosense Webster Inc – Ongoing Clinical Trials Overview 20

CARTO SMARTTOUCH 5D Catheter – Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF) 21

Thermocool Smarttouch SF Dual Energy Catheter – Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF) 22

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Next Generation IntellaTip Catheter – Product Status 23

Next Generation IntellaTip Catheter – Product Description 23

POLARx Next Generation Catheter – Product Status 24

POLARx Next Generation Catheter – Product Description 24

CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 25

HeartLight X3 System – Product Status 25

HeartLight X3 System – Product Description 25

CardioFocus Inc – Ongoing Clinical Trials Overview 26

HeartLight X3 System – A Prospective Multicenter U.S. Comparison of Radiofrequency, Cryoballoon and Laser Balloon Modalities for Pulmonary Vein Isolation Ablation in Patients with Atrial Fibrillation 27

CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Khelix Irrigated Ablation EP Catheter – Product Status 28

Khelix Irrigated Ablation EP Catheter – Product Description 28

Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Catheter-Based Carotid Body Ablation System – Product Status 29

Catheter-Based Carotid Body Ablation System – Product Description 29

CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 30

Cryotherapy System – Coronary Artery Disease – Product Status 30

Cryotherapy System – Coronary Artery Disease – Product Description 30

CryoTherapeutics SA – Ongoing Clinical Trials Overview 31

Cryotherapy System – Coronary Artery Disease – Clinical Investigation of Intracoronary Cryotherapy Using the CryoTherapy System (CTS) for High-risk Plaque in Patients with Non-ST Segment Elevation Myocardial Infarction (NSTEMI) or Unstable Angina 32

Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 33

Next Generation Ablation Catheter – Product Status 33

Next Generation Ablation Catheter – Product Description 33

Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 34

FARAFLEX – Product Status 34

FARAFLEX – Product Description 34

FARAONE – Product Status 35

FARAONE – Product Description 35

FARAPOINT – Product Status 35

FARAPOINT – Product Description 36

Next Gen FARAWAVE Catheter – Product Status 36

Next Gen FARAWAVE Catheter – Product Description 36

Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

ALPHA1 Ablation Catheter – Product Status 37

ALPHA1 Ablation Catheter – Product Description 37

Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 38

AblaView – Product Status 38

AblaView – Product Description 38

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 39

Voyager Irrigated RF Ablation Catheter – Product Status 39

Voyager Irrigated RF Ablation Catheter – Product Description 39

Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Cryoablation Catheter – Product Status 40

Cryoablation Catheter – Product Description 40

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 41

FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Status 41

FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Description 41

Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 42

MAGiC Ablation Catheter – Product Status 42

MAGiC Ablation Catheter – Product Description 42

Stereotaxis Inc – Ongoing Clinical Trials Overview 43

MAGiC Ablation Catheter – The MAGiC Cardiac Ablation Feasibility Study 44

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 45

Temperature Controlled Catheter – Product Status 45

Temperature Controlled Catheter – Product Description 45

Glossary 56

Figures

Advanced Ablation Catheters – Pipeline Products by Stage of Development 9

Advanced Ablation Catheters – Pipeline Products by Segment 10

Advanced Ablation Catheters – Pipeline Products by Territory 11

Advanced Ablation Catheters – Pipeline Products by Regulatory Path 12

Advanced Ablation Catheters – Pipeline Products by Estimated Approval Date 13

Advanced Ablation Catheters – Ongoing Clinical Trials 14

Frequently asked questions

Advanced Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Advanced Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Advanced Ablation Catheters reports
Medical Devices
New
Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | September 2026
Medical Devices
New
Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…
$7,500 | September 2026
Medical Devices
New
Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…
$7,500 | September 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Advanced Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Advanced Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more